Company / Financials
Ginkgo Bioworks Holdings, Inc. Financials
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$170.2M
FY2025 · -25.1% YoY
Net Income
-$312.8M
FY2025 · +42.8% YoY
Profit Margin
-183.8%
FY2025 · net income / revenue
ROE
-61.5%
FY2025 · return on equity
Total Assets
$1.1B
FY2025
Total Debt
-
FY2025
Equity
$508.6M
FY2025
ROA
-27.9%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$170.2M-25.1% YoYNet Income HistoryProfit after all expenses and taxes-$312.8M+42.8% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$315.3M+43.7% YoYSG&A Expense HistorySelling, general, and administrative expenses$183.3M-25.5% YoYR&D Expense HistoryResearch and development spending$243.8M-42.5% YoYInterest Expense HistoryCost of borrowing and debt obligations-Income Tax HistoryTotal income tax expense-$837.0K-74.7% YoYEPS (Basic) HistoryBasic earnings per share-$18.37+63.4% YoYEPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles-$18.37+63.4% YoYShares Outstanding HistoryWeighted average diluted shares outstanding54.4M+8.7% YoY